Pandorum Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 40

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $18M

  • Investors
  • 41

Pandorum General Information

Description

Developer of functional human tissues designed for tissue engineering and regenerative medicine. The company's experimental-stage human liver tissue is created using three-dimensional printing technology and acts as an artificial liver during liver failures or liver transplantation, and takes less time to regenerate for medical research and therapeutic applications, enabling surgeons to perform painless liver surgeries to advance regenerative therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • EGF 5, Bangalore Bioinnovation Centre
  • Bangalore Helix Biotech Park, Electronics City Phase 1
  • Bengaluru, Karnataka 560100
  • India
+91 098000
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • EGF 5, Bangalore Bioinnovation Centre
  • Bangalore Helix Biotech Park, Electronics City Phase 1
  • Bengaluru, Karnataka 560100
  • India
+91 098000

Pandorum Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pandorum Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC (Series B) 09-Feb-2026 $18M Completed Generating Revenue
13. Later Stage VC (Series A) 15-Mar-2024 Completed Generating Revenue
12. Accelerator/Incubator 14-Oct-2022 Completed Generating Revenue
11. Later Stage VC 20-Oct-2021 Completed Generating Revenue
10. Later Stage VC (Series B) 08-Sep-2020 Completed Generating Revenue
9. Later Stage VC (Series A) 13-Feb-2018 Completed Product Development
8. Angel (individual) 24-Dec-2016 Completed Startup
7. Grant 01-Jan-2014 Completed Startup
6. Grant 01-Jan-2012 $100K $450K Completed Startup
5. Angel (individual) $400K $450K Completed Startup
To view Pandorum’s complete valuation and funding history, request access »

Pandorum Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2 CCPS
Series A1 CCPS
Ordinary Shares
Preferance Shares
Preferance Shares
Preferance Shares 36,457 $14.199461 $72.14 $72.14 1x $72.14 14.14%
Ordinary Shares 8,702 $0.012064 $27.72 $27.72 1x $27.72 3.37%
To view Pandorum’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Pandorum Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of functional human tissues designed for tissue engineering and regenerative medicine. The company's experimen
Biotechnology
Bengaluru, India
40 As of 2026

Vancouver, Canada
 

Schlieren, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pandorum Competitors (6)

One of Pandorum’s 6 competitors is Aspect Biosystems, a Venture Capital-Backed company based in Vancouver, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aspect Biosystems Venture Capital-Backed Vancouver, Canada
InSphero Private Equity-Backed Schlieren, Switzerland
VivoSim Labs Formerly VC-backed San Diego, CA
Synthecon Formerly Accelerator/Incubator backed Houston, TX
Prothena Corporation Dublin, Ireland
To view Pandorum’s complete competitors history, request access »

Pandorum Patents

Pandorum Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026036123-A1 A corneal implant and process of preparation thereof Pending 08-Aug-2024
WO-2025259683-A1 Machine learning based assessment of biological and synthetic nanovesicles Pending 10-Jun-2024
WO-2025251061-A1 Method for scalable production of therapeutic exosomes Pending 31-May-2024
WO-2025251061-A9 Method for scalable production of therapeutic exosomes Pending 31-May-2024
EP-4820075-A1 A lenticule, method of preparation and implementations thereof Pending 04-Dec-2023 A61L27/26
To view Pandorum’s complete patent history, request access »

Pandorum Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pandorum Investors (41)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aeroflex Enterprises Venture Capital Minority
Auraplus Services Corporation Minority
Avinya Ventures Venture Capital Minority
Burman Family Family Office Minority
Galentic Pharma (India) Pvt. Corporation Minority
You’re viewing 5 of 41 investors. Get the full list »

Pandorum FAQs

  • When was Pandorum founded?

    Pandorum was founded in 2009.

  • Where is Pandorum headquartered?

    Pandorum is headquartered in Bengaluru, India.

  • What is the size of Pandorum?

    Pandorum has 40 total employees.

  • What industry is Pandorum in?

    Pandorum’s primary industry is Biotechnology.

  • Is Pandorum a private or public company?

    Pandorum is a Private company.

  • What is Pandorum’s current revenue?

    The current revenue for Pandorum is .

  • How much funding has Pandorum raised over time?

    Pandorum has raised $43.7M.

  • Who are Pandorum’s investors?

    Aeroflex Enterprises, Auraplus Services, Avinya Ventures, Burman Family, and Galentic Pharma (India) Pvt. are 5 of 41 investors who have invested in Pandorum.

  • Who are Pandorum’s competitors?

    Aspect Biosystems, InSphero, VivoSim Labs, Synthecon, and Prothena are some of the 6 competitors of Pandorum.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process